No shortage on file

JARDIANCE

BOEHRINGER INGELHEIM (CANADA) LTD LTEE

Quick answers

Is there a shortage of JARDIANCE in Canada?

No. There is no current shortage of JARDIANCE 25MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on file1 product

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

JARDIANCE

BOEHRINGER INGELHEIM (CANADA) LTD LTEE

10MG · DIN 02443937

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

DIN

02443945

Strength

25MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

EMPAGLIFLOZIN

See all EMPAGLIFLOZIN products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2020-05-13

Shortage Avoided

Disruption of the manufacture of the drug.

2020-04-22

Shortage Avoided

Disruption of the manufacture of the drug.

Other Products from BOEHRINGER INGELHEIM (CANADA) LTD LTEE

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

DIN 02242119

250MG · DIN 02273322

20MCG · DIN 02247686

DIN 02419106

DIN 02231675

0.4MG · DIN 02270102